Can diabetes and elderly age cause a decrease in Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diabetes and elderly age can potentially contribute to a decrease in Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC), though the relationship is not always direct. In diabetes, chronic inflammation and kidney dysfunction can impair erythropoietin production and iron metabolism, leading to reduced hemoglobin synthesis and subsequently lower MCH and MCHC values. Additionally, diabetic patients often experience oxidative stress that can shorten red blood cell lifespan. In elderly individuals, age-related changes in bone marrow function, nutritional deficiencies (particularly iron, vitamin B12, and folate), and chronic inflammation associated with aging can all contribute to decreased hemoglobin production. These conditions may present as microcytic or normocytic anemia with reduced MCH and MCHC. Regular monitoring of complete blood counts is important for diabetic and elderly patients, and any persistent decreases in these values should prompt further investigation for underlying causes such as iron deficiency, chronic disease anemia, or other nutritional deficiencies. Treatment typically addresses the underlying cause rather than the laboratory values directly, as supported by recent guidelines 1. It is essential to consider the individual's overall health, functional status, and preferences when determining the best course of treatment, as emphasized in the American Diabetes Association's standards of care for older adults with diabetes 1. The most recent guidelines from 2025 1 provide a framework for individualizing treatment goals and therapeutic approaches in older adults with diabetes, taking into account their clinical, cognitive, and functional heterogeneity. By prioritizing the patient's quality of life, functional status, and overall well-being, healthcare providers can develop effective treatment plans that address the complex needs of older adults with diabetes. In conclusion, while diabetes and elderly age may contribute to decreased MCH and MCHC, a comprehensive approach to diagnosis, treatment, and management is necessary to optimize outcomes and improve quality of life for these patients, as recommended by recent studies 1.

From the Research

Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC) in Diabetes and Elderly

  • The provided studies do not directly address the relationship between diabetes, elderly age, and a decrease in MCH and MCHC.
  • However, some studies discuss the effects of iron deficiency on MCH and MCHC. For example, a study from 2000 2 found that iron deficient patients had a highly significant difference in MCH levels, with 15% of iron deficient subjects also having coexisting vitamin B12 deficiency.
  • Another study from 2015 3 mentions that hypochromic-microcytic anemias, characterized by a hemoglobin deficiency of the erythrocytes, can be caused by iron deficiency anemia or anemia of chronic disorders, which may be relevant to elderly patients.
  • A study from 1976 4 suggests that iron deficiency can progress through three stages, with anisocytosis and an increased percentage of microcytic cells being the first haematological abnormalities to occur, followed by a decline in MCV and MCH, and finally a low MCHC.
  • A 2015 review 5 discusses the diagnosis of iron-deficient states and mentions that new hematological parameters such as reticulocyte Hb content have expanded the classic ones such as MCV, MCH, and MCHC.
  • A case report from 2016 6 describes a patient with glucose-6-phosphate dehydrogenase deficiency who developed hemolytic anemia after starting metformin, but does not provide information on MCH or MCHC levels.

Iron Deficiency and MCH/MCHC

  • Iron deficiency anemia can cause a decrease in MCH and MCHC, as seen in studies from 2000 2, 1976 4, and 2015 3, 5.
  • The relationship between diabetes, elderly age, and iron deficiency is not clearly established in the provided studies, but it is known that elderly people are at high risk of iron deficiency anemia 3.

Diabetes and MCH/MCHC

  • There is limited information in the provided studies on the direct relationship between diabetes and MCH/MCHC levels.
  • However, a case report from 2016 6 describes a patient with diabetes who developed hemolytic anemia after starting metformin, but does not provide information on MCH or MCHC levels.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Research

Diagnosis of iron-deficient states.

Critical reviews in clinical laboratory sciences, 2015

Related Questions

What is the next step in managing a patient with mild hypochromia and microcytosis?
What is the management plan for a patient with anisocytosis, microcytosis, and poikilocytosis?
What is the differential diagnosis for a 62-year-old patient with anemia, slight elevation of C-Reactive Protein (CRP), erosion in the metatarsal, swelling, and warmth in the forefoot?
What is the most likely diagnosis for a 2-year-old girl with pallor, history of excessive cow's milk intake, picky eating habits, low Red Blood Cell (RBC) count, severe hypochromia (low Hemoglobin (Hb) and Mean Corpuscular Hemoglobin (MCH)), microcytosis (low Mean Corpuscular Volume (MCV)), elevated Reticulocyte count, thrombocytosis (high Platelet count), and low Ferritin levels?
What are the implications of a blood smear showing moderate anisocytosis (unequal size of red blood cells), moderate hypochromasia (reduced hemoglobin), and mild poikilocytosis (variation in shape of red blood cells)?
What type of duplex ultrasound is best for AAA (Abdominal Aortic Aneurysm) patients post EVAR (Endovascular Aneurysm Repair)?
What is the best approach to manage iron deficiency anemia in a 92-year-old diabetic patient?
What is the initial treatment for patients with diabetes and impaired renal function, specifically those with an estimated glomerular filtration rate (eGFR) of 30 mL/minute/1.73 m² or higher?
Should an 83-year-old woman with Parkinson's disease, taking sertraline (an selective serotonin reuptake inhibitor (SSRI)) for stress for several years without side effects, continue her current regimen given the potential risk of serotonin syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question